Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Journal of Medicinal Chemistry|April 1, 1991
Synthesis and biochemical evaluation of baclofen analogues locked in the baclofen solid-state conformationA Mann, T Boulanger, B Brandau, et al.British Journal of Pharmacology|January 1, 1987
A 7-phenyl substituted triazolopyridazine has inverse agonist activity at the benzodiazepine receptor siteK Biziere, J J Bourguignon, J P Chambon, et al.Journal of Medicinal Chemistry|May 29, 1992
Structure and molecular modeling of GABAA receptor antagonistsD Rognan, T Boulanger, R Hoffmann, et al.Biochemical and Biophysical Research Communications|June 29, 1983
Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activityC Lugnier, A Stierlé, A Beretz, et al.Biochemical and Biophysical Research Communications|August 15, 1985
Photoaffinity labeling of D-2 dopamine binding subunits from rat striatum, anterior pituitary and olfactory bulb with a new probe, [3H]azidosulprideK Redouane, P Sokoloff, J C Schwartz, et al.Life Sciences|March 15, 1982
High affinity binding sites for gamma-hydroxybutyric acid in rat brainJ Benavides, J F Rumigny, J J Bourguignon, et al.Nature|August 4, 1999
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonistM Pilla, S Perachon, F Sautel, et al.Journal of Medicinal Chemistry|March 1, 1989
3-aminopyridazine derivatives with atypical antidepressant, serotonergic, and dopaminergic activitiesC G Wermuth, G Schlewer, J J Bourguignon, et al.European Journal of Pharmacology|July 18, 1989
Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonistC Schumacher, R Steinberg, J P Kan, et al.European Journal of Pharmacology|January 2, 1985
The use of [3H](-)-DO 710 as selective dopaminergic ligand for binding and autoradiographic studiesP Sokoloff, M Brann, K Redouane, et al.Pageof 7